Arkolith/Insider Trading/ACXP/Form 4

Deluccia Robert J

Director, 10% OwnerAcurx Pharmaceuticals, Inc. (ACXP) · full profile →Form 4 · filed Jan 4, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
4 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2024Option exercise(M)20K$3.55$70K961K
Dec 22, 2023Gift(G)30K—$0941K
Dec 12, 2023Gift(G)40K—$0971K
Dec 2, 2021Gift(G)40K—$01.0M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2024Option exercise(M)20K—$00

Transaction Codes

M
Option exercise / conversion
G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-001375) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML